Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study

Laura K. Ferris; Darrell S. Rigel; Daniel M. Siegel; Maral K. Skelsey; Gary L. Peck; Catherine Hren; Christopher Gorman; Tana Frumento; Burkhard Jansen; Zuxu Yao; Jim Rock; Stevan R. Knezevich; Clay J. Cockerell

ArticleOPEN ACCESS

Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study

Dermatology online journal

DOI: 10.5070/d3255044059

1Citations

9Readers

Abstract

The revised version of the article corrected Figure 2. This change appears in the revised online PDF copy of this article.

Cite

CITATION STYLE

APA

Ferris, L. K., Rigel, D. S., Siegel, D. M., Skelsey, M. K., Peck, G. L., Hren, C., … Cockerell, C. J. (2019, June 6). Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study. Dermatology Online Journal. NLM (Medline). https://doi.org/10.5070/d3255044059

Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study

Abstract

Cite

Register to see more suggestions